| New anticonvulsants in pediatrics: carbamazepine and valproate. | |
| | |
MedLine Citation:
|
PMID: 3105964 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The majority of patients with epilepsy have their first seizure during childhood and are first evaluated and diagnosed by their pediatrician. For many patients the medication selected by the pediatrician will be taken for an extended time period, perhaps even for a lifetime. The first job of the pediatrician is to be sure that the patient's recurrent attacks represent genuine epilepsy and not some other paroxysmal medical disorder such as migraine or cardiac arrhythmias. Epileptic seizures are then classified by a careful clinical description of the attacks in conjunction with the results of the physical and EEG examinations. Based on all of the information at hand, the clinician chooses the drug that is most likely to reduce or eliminate further seizures without exposing the child to unnecessary medical risk or behavioral-cognitive adverse effects. In properly selected patients, both carbamazepine and valproate are safe, physically well tolerated, and less likely to provoke chronic mental side effects than the pediatrician's "traditional" choices: phenobarbital or phenytoin. Although carbamazepine and valproate have been widely acclaimed by neurologists and epileptologists, practicing pediatricians have heretofore been less likely to initiate treatment with these drugs. Yet pediatricians have something of priceless value to offer the child with epilepsy: seizure control and a clear mind. The information in this monograph should assist the practicing pediatrician in the rational choice, initiation, and follow-up of treatment with these two excellent anticonvulsants. |
| | |
Authors:
|
R R Clancy |
Related Documents
:
|
7007674 - Van gogh's vision. digitalis intoxication? 10327384 - Psychosocial side effects of sildenafil therapy for erectile dysfunction. 19039694 - The convergent and divergent validity of the matson evaluation of drug side-effects (me... 23163014 - Right there all along. latest iom report lays out how to deliver safer, more effective ... 17101054 - Evaluation of herbal cannabis characteristics by medical users: a randomized trial. 17945954 - Fragility issues of medical video streaming over 802.11e-wlan m-health environments. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current problems in pediatrics Volume: 17 ISSN: 0045-9380 ISO Abbreviation: Curr Probl Pediatr Publication Date: 1987 Mar |
Date Detail:
|
Created Date: 1987-05-28 Completed Date: 1987-05-28 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 1272515 Medline TA: Curr Probl Pediatr Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 133-209 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Carbamazepine / adverse effects, therapeutic use* Child Child, Preschool Electroencephalography Epilepsy / drug therapy* Female Humans Male Substance Withdrawal Syndrome Valproic Acid / adverse effects, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
298-46-4/Carbamazepine; 99-66-1/Valproic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Factors affecting ascorbate oxidation in aqueous humor.
Next Document: Endobronchial tuberculosis. Serial fiberoptic bronchoscopy and natural history.